MedAdvisor signs binding agreement to acquire Guild Link Pty Limited

Jul 25, 2022

MedAdvisor Limited (ASX: MDR) has signed a binding agreement to acquire GuildLink Pty Limited from Guild Group Holdings Limited. The acquisition of GuildLink Pty Limited would enable the Company to provide an improved platform that eliminates duplication and increases efficiencies for the benefit of Australian pharmacies.

The Pharmacy Guild of Australia will work in partnership with MedAdvisor to develop as well as deliver new and ongoing health service initiatives together with government programs to provide and support the health requirements of communities across Australia.

The acquisition of GuildLink will be funded by MedAdvisor via the issue of 57,118,490 fully paid ordinary shares in MDR to Guild Group, which is 15% of MDR’s issued capital.

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au